MedCity News
MARCH 3, 2024
A federal judge disagreed with AstraZeneca’s claims that the Inflation Reduction Act causes harm by disincentivizing innovation and violates its constitutional rights to due process. Blockbuster AstraZeneca drug Farxiga is one of 10 medications selected for the Medicare drug price negotiation program created by the law.
pharmaphorum
MARCH 3, 2024
Avidity Biosciences files $400m private placement as it prepares for phase 3 trial of lead antibody oligonucleotide conjugate AOC 1001 in rare disease DM1
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 3, 2024
By implementing workforce management technology to support the people who take care of the patients, health systems can ensure that merger and acquisition activity is a success.
pharmaphorum
MARCH 3, 2024
Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug pricing negotiation under the Inflation Reduction Act
MedCity News
MARCH 3, 2024
March is Lymphedema Awareness Month, and today there are more options than ever to help prevent this challenging and all too common complication associated with breast cancer treatment.
PharmaTech
MARCH 3, 2024
CPHI North America is a three-day event offering opportunities to learn, innovate, and network in the pharmaceutical industry.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTech
MARCH 3, 2024
The 6th Treg-Directed Therapies Summit will feature leading industry and academic experts in the Treg therapy field.
MedCity News
MARCH 3, 2024
The future of American healthcare hinges on the continued support and elevation of independent primary care—a cornerstone that not only enhances healthcare quality and cost controls but also ensures a healthier and more equitable future for all.
Expert insights. Personalized for you.
132 
Let's personalize your content